Deadly ‘MDR Superbugs’ Invade U.S. Health Care Facilities

USA TODAY recently ran an article, “Deadly ‘superbugs’ invade U.S. health care facilities“.  The article is not only timely but was well-researched and did a good job of putting multi-drug resistant micro-organisms (“MDR Superbugs”) back into the spotlight; at least, for the moment.  Of course, readers of the Bio/Tech News have known about this potential threat for years now.  But to the extent USA TODAY has contributed to the effort to raise the general awareness about this real and growing threat, we applaud them.


All In Your Head?

Breakthrough in NeuroScience Offers You Hope for a Multitude of Brain Diseases and Neurological Disorders–Without Drugs and Without Side-Effects!
Our aim in this Special Report (click here) is to give you two things to take away with you: 1) a basic understanding of what we call “Neurotransmitter Disease” and how it is that it presents with so many apparently diverse and varied symptoms (see below); and, 2) an understanding of how, in many cases, it might be possible for you or a loved one to secure a simple, non-drug solution to this widespread, increasingly common problem.


Surviving a Hospital Stay

When it comes to the matter of Hospital-acquired Infections (HAIs) the situation here in the US is becoming dangerous enough that you really don’t want to spend time in a hospital if there’s any way to avoid it.  To get a feel for how serious the situation has become, see the section “Death By Medicine” in our recent Special Report, “Superbugs: the Coming Deadly Global Pandemic”, which is posted on this website for your convenience.

The Committee to Reduce Infection Deaths (RID) has published a brief and helpful article, “15 Steps You Can Take to Reduce Your Risk of a Hospital Infection”.  RID is chaired by former Lt. Governor of New York, Dr. Betsy McCaughey.  Dr. McCaughey has been a strong patient advocate since 2004 and has been very effective in raising public awareness of the problem of Hospital-acquired Infections.  We encourage you to visit RID’s website for more information: